Vedolizumab Treatment of Refractory Immune Checkpoint Inhibitor Colitis

被引：0
|
作者：
McNally, Bridgette B. [1 ]
Sivakumar, Angiela [1 ]
Haddad, Nael [2 ]
Suchartlikitwong, Sakolwan [1 ]
Aguon, Paul Muna [1 ]
Fung, Brian M. [1 ]
Zucker, Kelly [1 ]
David, Joseph [1 ]
机构：
[1] Univ Arizona, Coll Med, Phoenix, AZ USA
[2] Univ Arizona, Phoenix, AZ USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2021年 / 116卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
S1696
引用
收藏
页码：S756 / S756
页数：1
相关论文
共 50 条
  • [1] Vedolizumab for steroid & infliximab refractory immune checkpoint inhibitor associated colitis
    Klemm, Natasha
    Trasolini, Roberto
    Chahal, Daljeet
    Donnellan, Fergal
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2021, 45 (04)
  • [2] Infliximab Versus Vedolizumab in Outpatient Treatment of Immune Checkpoint Inhibitor Colitis
    Joseph, Joel A.
    Townsend, Matthew J.
    Somappa, Aakash K.
    Sack, Jordan
    Leboeuf, Nicole R.
    Sharon, Elad
    Grover, Shilpa
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S164 - S165
  • [3] CMV coinfection in treatment refractory immune checkpoint inhibitor colitis
    Harris, Kevin B.
    Funchain, Pauline
    Baggott, Brian B.
    BMJ CASE REPORTS, 2020, 13 (05)
  • [4] Vedolizumab in the treatment of immune checkpoint inhibitor-induced colitis: Two case reports
    Zhang, Zhe
    Zheng, Chang-Qing
    WORLD JOURNAL OF CLINICAL CASES, 2022, 10 (29) : 10550 - 10558
  • [5] Vedolizumab in the treatment of immune checkpoint inhibitor-induced colitis: Two case reports
    Zhang, Zhe
    Zheng, Chang-Qing
    FRONTIERS IN ONCOLOGY, 2022, 12 : 10550 - 10558
  • [6] A case of refractory immune checkpoint inhibitor-induced colitis improved by the treatment with vedolizumab and granulocyte–monocyte apheresis combination therapy
    Hikaru Ishihara
    Tatsuyuki Watanabe
    Shinsuke Kumei
    Keiichiro Kume
    Ichiro Yoshikawa
    Masaru Harada
    Clinical Journal of Gastroenterology, 2024, 17 : 46 - 51
  • [7] Biologic Therapy for Refractory Immune Checkpoint Inhibitor Colitis
    Alorfi, Nasser M.
    Alourfi, Mansour Marzouq
    BIOLOGICS-TARGETS & THERAPY, 2022, 16 : 119 - 127
  • [8] A case of refractory immune checkpoint inhibitor-induced colitis improved by the treatment with vedolizumab and granulocyte-monocyte apheresis combination therapy
    Ishihara, Hikaru
    Watanabe, Tatsuyuki
    Kumei, Shinsuke
    Kume, Keiichiro
    Yoshikawa, Ichiro
    Harada, Masaru
    CLINICAL JOURNAL OF GASTROENTEROLOGY, 2024, 17 (01) : 46 - 51
  • [9] Vedolizumab treatment for immune checkpoint inhibitor-induced enterocolitis
    Viktoria Bergqvist
    Erik Hertervig
    Peter Gedeon
    Marija Kopljar
    Håkan Griph
    Sara Kinhult
    Ana Carneiro
    Jan Marsal
    Cancer Immunology, Immunotherapy, 2017, 66 : 581 - 592
  • [10] Efficacy of Infliximab and Vedolizumab in Immune Checkpoint Inhibitor Colitis: A Meta-Analysis
    Zuberi, Shaharyar
    Anderson, Kelsey
    Porth, Rachel
    Taneja, Vikas
    Feuerstein, Joseph D.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S229 - S231
12345